What is the optimal mode of mechanical support in transplanted patients with acute graft failure?

Marian Urban, Ondrej Szarszoi, Jan Pirk, Ivan Netuka

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: is extracorporeal membrane oxygenation (ECMO) superior to dedicated ventricular assist device (VAD) in patients with acutely failing allograft following transplantation. Altogether, 162 papers were found using the reported search, of which 8 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Two studies provide data only for ECMO-treated patients, in three, the authors describe their experiences with Levitronix CentriMag and three studies directly compare the outcomes of ECMO and VAD support. The survival ranges from 40 to 74 in patients rescued with ECMO compared with 33-60 in patients supported with dedicated VAD. We conclude that there is insufficient evidence to prefer ECMO over VAD and the optimal modality of mechanical circulatory support (MCS) following heart transplantation should be determined by the surgeon and institutional experience and dependent on the extent and severity of myocardial dysfunction and the presence or absence of associated respiratory insufficiency.

Original languageEnglish (US)
Pages (from-to)517-519
Number of pages3
JournalInteractive cardiovascular and thoracic surgery
Volume16
Issue number4
DOIs
StatePublished - Apr 1 2013

Fingerprint

Extracorporeal Membrane Oxygenation
Heart-Assist Devices
Transplants
Heart Transplantation
Respiratory Insufficiency
Thoracic Surgery
Allografts
Publications
Transplantation
Outcome Assessment (Health Care)
Survival

Keywords

  • Circulatory assist devices
  • Extracorporeal membrane oxygenation
  • Review Transplantation, heart

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

What is the optimal mode of mechanical support in transplanted patients with acute graft failure? / Urban, Marian; Szarszoi, Ondrej; Pirk, Jan; Netuka, Ivan.

In: Interactive cardiovascular and thoracic surgery, Vol. 16, No. 4, 01.04.2013, p. 517-519.

Research output: Contribution to journalArticle

@article{81cbf0684a6c426e9309c297e5a81483,
title = "What is the optimal mode of mechanical support in transplanted patients with acute graft failure?",
abstract = "A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: is extracorporeal membrane oxygenation (ECMO) superior to dedicated ventricular assist device (VAD) in patients with acutely failing allograft following transplantation. Altogether, 162 papers were found using the reported search, of which 8 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Two studies provide data only for ECMO-treated patients, in three, the authors describe their experiences with Levitronix CentriMag and three studies directly compare the outcomes of ECMO and VAD support. The survival ranges from 40 to 74 in patients rescued with ECMO compared with 33-60 in patients supported with dedicated VAD. We conclude that there is insufficient evidence to prefer ECMO over VAD and the optimal modality of mechanical circulatory support (MCS) following heart transplantation should be determined by the surgeon and institutional experience and dependent on the extent and severity of myocardial dysfunction and the presence or absence of associated respiratory insufficiency.",
keywords = "Circulatory assist devices, Extracorporeal membrane oxygenation, Review Transplantation, heart",
author = "Marian Urban and Ondrej Szarszoi and Jan Pirk and Ivan Netuka",
year = "2013",
month = "4",
day = "1",
doi = "10.1093/icvts/ivs546",
language = "English (US)",
volume = "16",
pages = "517--519",
journal = "Interactive Cardiovascular and Thoracic Surgery",
issn = "1569-9293",
publisher = "European Association for Cardio-Thoracic Surgery",
number = "4",

}

TY - JOUR

T1 - What is the optimal mode of mechanical support in transplanted patients with acute graft failure?

AU - Urban, Marian

AU - Szarszoi, Ondrej

AU - Pirk, Jan

AU - Netuka, Ivan

PY - 2013/4/1

Y1 - 2013/4/1

N2 - A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: is extracorporeal membrane oxygenation (ECMO) superior to dedicated ventricular assist device (VAD) in patients with acutely failing allograft following transplantation. Altogether, 162 papers were found using the reported search, of which 8 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Two studies provide data only for ECMO-treated patients, in three, the authors describe their experiences with Levitronix CentriMag and three studies directly compare the outcomes of ECMO and VAD support. The survival ranges from 40 to 74 in patients rescued with ECMO compared with 33-60 in patients supported with dedicated VAD. We conclude that there is insufficient evidence to prefer ECMO over VAD and the optimal modality of mechanical circulatory support (MCS) following heart transplantation should be determined by the surgeon and institutional experience and dependent on the extent and severity of myocardial dysfunction and the presence or absence of associated respiratory insufficiency.

AB - A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: is extracorporeal membrane oxygenation (ECMO) superior to dedicated ventricular assist device (VAD) in patients with acutely failing allograft following transplantation. Altogether, 162 papers were found using the reported search, of which 8 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Two studies provide data only for ECMO-treated patients, in three, the authors describe their experiences with Levitronix CentriMag and three studies directly compare the outcomes of ECMO and VAD support. The survival ranges from 40 to 74 in patients rescued with ECMO compared with 33-60 in patients supported with dedicated VAD. We conclude that there is insufficient evidence to prefer ECMO over VAD and the optimal modality of mechanical circulatory support (MCS) following heart transplantation should be determined by the surgeon and institutional experience and dependent on the extent and severity of myocardial dysfunction and the presence or absence of associated respiratory insufficiency.

KW - Circulatory assist devices

KW - Extracorporeal membrane oxygenation

KW - Review Transplantation, heart

UR - http://www.scopus.com/inward/record.url?scp=84875131364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875131364&partnerID=8YFLogxK

U2 - 10.1093/icvts/ivs546

DO - 10.1093/icvts/ivs546

M3 - Article

C2 - 23277596

AN - SCOPUS:84875131364

VL - 16

SP - 517

EP - 519

JO - Interactive Cardiovascular and Thoracic Surgery

JF - Interactive Cardiovascular and Thoracic Surgery

SN - 1569-9293

IS - 4

ER -